A physiologic model for simulating gastrointestinal flow and drug absorption in rats

Area of Science:

• Pharmacokinetics
• Drug Absorption Modeling
• Physiologically Based Pharmacokinetic (PBPK) Modeling

Background:

• Accurate prediction of oral drug absorption is crucial for effective drug development.
• Existing multicompartmental models have limitations in representing the continuous nature of the gastrointestinal (GI) tract.
• A need exists for sophisticated models that integrate physiological and physicochemical parameters for precise absorption profiling.

Purpose of the Study:

• To develop and describe a novel physiologically based absorption model for orally administered drugs in rats.
• To represent the GI tract as a continuous tube with dynamic, spatially varying properties.
• To enable calculation of complete temporal and spatial absorption profiles using minimal substance-specific parameters.

Main Methods:

• The gastrointestinal tract is modeled as a continuous tube, departing from traditional multicompartmental approaches.
• Intestinal transit is described using an intestinal transit function to model mass transport.
• Key substance-specific inputs include intestinal permeability coefficient and solubility in intestinal fluid.

Main Results:

• The model demonstrated excellent agreement between simulated and measured portal vein drug concentrations in initial performance tests.
• It accurately described the dose-dependent absorption of chlorothiazide, a compound with solubility-limited absorption.
• The model successfully predicted temporal absorption profiles, validating its predictive capabilities.

Conclusions:

• The developed continuous absorption model is highly effective for simulating drug flow and absorption within the rat GI tract.
• This model offers a valuable tool for advancing pharmacokinetic studies and drug development in preclinical settings.
• Its ability to integrate physiological and physicochemical data enhances the understanding of drug absorption dynamics.